Therapeutic decisions for glaucoma patients weigh benefits

Chicago-IOP control remains the basis for primary treatment of glaucoma, but there have been some recent changes in the medical and surgical arenas. Now, a prostaglandin analogue is often used instead of a beta-blocker as first-line therapy, selective laser trabeculoplasty (SLT) has emerged as another option for primary laser surgery, and meanwhile, there is growing patient interest in complementary medicine alternatives.